Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2005
09/22/2005CA2559065A1 Identification of self and non-self antigens implicated in autoimmune diseases
09/22/2005CA2559062A1 Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
09/22/2005CA2559055A1 Modified oncolytic viruses
09/22/2005CA2558976A1 Mvl, an antiviral protein from a cyanobacterium
09/22/2005CA2558911A1 Process for producing polypeptides
09/22/2005CA2558811A1 Dimeric fusion proteins and materials and methods for producing them
09/22/2005CA2558632A1 Improved interleukin-2 muteins
09/22/2005CA2558621A1 Promoter from maize prolamin seed storage protein and uses thereof
09/22/2005CA2558050A1 Methods and compositions for the treatment of gastrointestinal disorders
09/22/2005CA2558047A1 A canine vaccine for protection against ehrlichiosis
09/22/2005CA2558041A1 Polynucleotides for the detection of escherichia coli o157
09/22/2005CA2558039A1 Treating or preventing extracellular matrix build-up
09/22/2005CA2558025A1 Cell-penetrating socs polypeptides that inhibit cytokine-induced signaling
09/22/2005CA2557668A1 High efficiency peptide production in plant cells
09/22/2005CA2557633A1 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics
09/22/2005CA2557374A1 Mutant proteins in the dna-binding domain of a trlomeric protein, trf2, and telomeric dna mutants, and use of the complex structure of the trf2 dna-binding domain and telomeric dna
09/22/2005CA2555792A1 Therapeutic administration of the scrambled anti-angiogenic peptide c16y
09/22/2005CA2555541A1 Cd38 splice variant and uses thereof
09/22/2005CA2476028A1 Novel purified polypeptides from staphylococcus pneumoniae
09/21/2005EP1577673A1 The use of BNP-type and ANP-type peptides for assessing the risk of suffering from a cardiovascular complication as a consequence of volume overload
09/21/2005EP1577671A1 Diagnostic drugs for autoimmune diseases
09/21/2005EP1577393A1 PRIMER AND PROBE FOR DETECTING i VIBRIO CHOLERAE /i OR i VIBRIO MIMICUS /i AND DETECTION METHOD USING THE SAME
09/21/2005EP1577391A1 Neutrokine alpha
09/21/2005EP1577390A1 Human cancer-relating genes, the products encoded thereby and applications thereof
09/21/2005EP1577388A1 Adiponectin promoter and use thereof
09/21/2005EP1577387A1 Preventives/remedies for cancer
09/21/2005EP1577384A1 Plant with reduced protein content in seed, method of constructing the same and method of using the same
09/21/2005EP1577383A1 Novel adaptor protein binding to mammalian toll-like receptor 3 and gene thereof
09/21/2005EP1577382A2 Detection of TSE infectivity
09/21/2005EP1577379A1 Defined culture medium
09/21/2005EP1577323A1 Metastin derivative and use thereof
09/21/2005EP1577322A1 Novel proteins and use thereof
09/21/2005EP1577321A1 Hydrophobically-modified protein compositions and methods
09/21/2005EP1577320A1 Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides
09/21/2005EP1576967A1 Recombinant protein, carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof, therapeutic uses thereof
09/21/2005EP1576964A1 Protease inhibitor
09/21/2005EP1576877A1 Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals
09/21/2005EP1576350A2 Peptides for detection of antibody to a. phagocytophila
09/21/2005EP1576182A2 Product quality enhancement in mammalian cell culture processes for protein production
09/21/2005EP1576178A2 Cell proliferation-related polypeptides and uses therefor
09/21/2005EP1576171A2 Amino acid transporters
09/21/2005EP1576170A2 Nucleic acids and corresponding proteins entitled 191p4d12(b) useful in treatment and detection of cancer
09/21/2005EP1576169A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576168A2 Therapeutic polypeptides nucleic acids encoding same and methods of use
09/21/2005EP1576163A2 High-protein-phenotype-associated plant genes
09/21/2005EP1576162A1 Chimeric protein for the screening of agonists and antagonists of cell signalling pathways that are dependent on g-protein-coupled receptors
09/21/2005EP1576159A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
09/21/2005EP1576158A2 Actinobacillus pleuropneumoniae virulence genes
09/21/2005EP1576157A1 Fluorescent proteins from copepoda species and methods for using same
09/21/2005EP1576156A1 Dec-205 (ly 75) / dcl-1 intergenic splice variants associated with hodkin's disease, and uses thereof
09/21/2005EP1576148A2 Process for coating cell-culture support
09/21/2005EP1576144A2 Proteorhodopsin mutants with improved optical characteristics
09/21/2005EP1576141A2 Polynucleotide encoding novel human g-protein coupled receptors, and splice variants thereof
09/21/2005EP1576139A2 Dep-1 receptor protein tyrosine phosphatase interacting proteins and related methods
09/21/2005EP1576138A2 2-branched nucleosides and flaviviridae mutation
09/21/2005EP1576137A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1576135A2 Method for regulating dopamine producing cells
09/21/2005EP1576132A2 Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer
09/21/2005EP1576130A2 Nucleic acids and corresponding proteins entitled 282p1g3 useful in treatment and detection of cancer
09/21/2005EP1576129A2 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same
09/21/2005EP1576128A2 Products and processes for modulating peptide-peptide binding domain interactions
09/21/2005EP1576125A2 Activation of hcv-specific cells
09/21/2005EP1576124A2 Heat shock protein binding fragments of cd91, and uses thereof
09/21/2005EP1576122A2 Isolated mammalian membrane protein genes; related reagents
09/21/2005EP1576120A2 Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens
09/21/2005EP1576119A2 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
09/21/2005EP1576116A2 Methods and materials relating to novel polypeptides and polynucleotides
09/21/2005EP1576115A2 Protein chips
09/21/2005EP1576114A2 Compositions and methods for controlling parasitic nematodes
09/21/2005EP1576113A2 Tumor antigens bfa4 and bcy1 for prevention and/or treatment of cancer
09/21/2005EP1576112A2 Cytokine receptor zcytor17 multimers
09/21/2005EP1576111A2 Cancer-linked gene as target for chemotherapy
09/21/2005EP1576109A2 Methods and compositions for categorizing patients
09/21/2005EP1576107A2 Abiz phage resistance gene
09/21/2005EP1576106A2 Process and materials for production of glucosamine and n-acetylglucosamine
09/21/2005EP1576104A2 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer
09/21/2005EP1576103A2 Isolated polynucleotides and methods of promoting a morphology in a fungus
09/21/2005EP1576102A2 Amidases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576101A2 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
09/21/2005EP1576098A2 A human cell assay to determine effect of sample compounds on col2 enhancer expression
09/21/2005EP1576097A2 Multimeric ligands with enhanced stability
09/21/2005EP1576090A2 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences
09/21/2005EP1576088A2 Dominant negative proteins and methods thereof
09/21/2005EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576042A2 Optical information carrier comprising immobilized proteorhodopsin
09/21/2005EP1576009A2 Novel fibulin-like polypeptides
09/21/2005EP1576008A2 Novel fibrillin-like polypeptides
09/21/2005EP1576007A2 Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders
09/21/2005EP1576006A2 Novel preadipocyte factor-1-like polypeptides
09/21/2005EP1576005A2 Notch-like polypeptides
09/21/2005EP1576004A2 An immunomodulatory protein derived from trypanosomes and uses thereof
09/21/2005EP1576003A1 Peptides for preventing, diagnosing and treating animal and/or human leptospirosis
09/21/2005EP1576002A2 Peptide oligomers for use as hiv vaccines
09/21/2005EP1576001A2 Endothelial cell specifically binding peptides
09/21/2005EP1575999A2 Increasing production of proteins in gram-positive microorganisms
09/21/2005EP1575998A2 Mammalian cell culture processes for protein production
09/21/2005EP1575995A2 Activation of peptide prodrugs by hk2
09/21/2005EP1575994A2 Mage-c2 antigenic peptides and uses thereof
09/21/2005EP1575993A2 Methods for treating patients and identifying therapeutics
09/21/2005EP1575992A2 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
1 ... 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 ... 2916